ASCO 2018 - Timothy B Johnson on partnering with QIAGEN to provide an entire workflow

Interview with TJ Johnson, CEO of HTG Molecular, on the development of new oncology offerings with pharmaceutical companies and how QIAGEN and HTG have partnered to provide an entire workflow from biomarker discovery to companion diagnostic development.